The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2020

Filed:

Apr. 07, 2017
Applicant:

Millipede, Inc., Santa Rosa, CA (US);

Inventors:

Randall Lashinski, Windsor, CA (US);

Matthew Rust, Windsor, CA (US);

Patrick Macaulay, Windsor, CA (US);

Terry Wayne Daniels, Occidental, CA (US);

Kris Kristoffersen, Redding, CA (US);

Assignee:

BOSTON SCIENTIFIC SCIMED, INC., Maple Grove, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/02 (2006.01); A61F 2/24 (2006.01); A61F 2/93 (2013.01); A61F 2/915 (2013.01); A61B 17/064 (2006.01); A61F 2/95 (2013.01);
U.S. Cl.
CPC ...
A61F 2/02 (2013.01); A61F 2/24 (2013.01); A61F 2/2409 (2013.01); A61F 2/2412 (2013.01); A61F 2/2442 (2013.01); A61F 2/2445 (2013.01); A61F 2/2463 (2013.01); A61F 2/2466 (2013.01); A61B 2017/0649 (2013.01); A61F 2/2418 (2013.01); A61F 2/93 (2013.01); A61F 2002/91591 (2013.01); A61F 2002/9534 (2013.01); A61F 2210/0023 (2013.01); A61F 2220/0016 (2013.01); A61F 2220/0033 (2013.01); A61F 2220/0091 (2013.01); A61F 2230/0065 (2013.01); A61F 2230/0069 (2013.01); A61F 2250/001 (2013.01); A61F 2250/0006 (2013.01);
Abstract

Excessive dilation of the annulus of a mitral valve may lead to regurgitation of blood during ventricular contraction. This regurgitation may lead to a reduction in cardiac output. Disclosed are systems and methods relating to an implant configured for reshaping a mitral valve. The implant comprises a plurality of struts with anchors for tissue engagement. The implant is compressible to a first, reduced diameter for transluminal navigation and delivery to the left atrium of a heart. The implant may then expand to a second, enlarged diameter to embed its anchors to the tissue surrounding and/or including the mitral valve. The implant may then contract to a third, intermediate diameter, pulling the tissue radially inwardly, thereby reducing the mitral valve and lessening any of the associated symptoms including mitral regurgitation.


Find Patent Forward Citations

Loading…